iBio (IBIO) Net Equity Issued and Repurchased (2012 - 2026)

iBio (IBIO) has 11 years of Net Equity Issued and Repurchased data on file, last reported at $3.3 million in Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased rose 193.7% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $5.9 million, a 61.56% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 86.13% from the prior year.
• Net Equity Issued and Repurchased for Q1 2026 stood at $3.3 million, up from $219000.0 in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for IBIO reached as high as $14.3 million in Q2 2024 and fell as low as $4000.0 in Q3 2024.
• Historically, Net Equity Issued and Repurchased has averaged $3.2 million across 4 years, with a median of $2.4 million in 2025.
• Across the five-year window, Net Equity Issued and Repurchased sank 99.86% in 2024 and soared 5375.0% in 2025, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $100000.0 in 2023, then plunged by 96.0% to $4000.0 in 2024, then surged by 5375.0% to $219000.0 in 2025, then soared by 1411.42% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $3.3 million in Q1 2026, $219000.0 in Q3 2025, and $2.4 million in Q2 2025.